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Abstract
In the present study, we evaluated the presence and the level of expression of HSP10 in two carcinogenetic models: the
‘adenoma–carcinoma sequence’ of large bowel and the ‘dysplasia–carcinoma sequence’ of uterine exocervix. We found
HSP10 was overexpressed during the carcinogenesis of both organs. In particular, HSP10 was overexpressed early in large
bowel carcinogenesis, while the expression of this protein in exocervical carcinogenesis gradually increased from normal
through dysplastic to neoplastic tissues. The quantitative analysis of immunohistochemistry and the Western blotting confirmed
these results. Our previous observations showed overexpression of HSP60 in the same carcinogenetic models. This report
correlates the overexpression of HSP10 with that of HSP60 during carcinogenesis in vivo. These results could stimulate further
studies on the pathogenetic role of these proteins during the carcinogenesis as well as their use as diagnostic and prognostic
tools in oncology.
q 2003 Elsevier Science Ltd. All rights reserved.
Keywords: Heat shock proteins; Carcinogenesis; Dysplasia; Carcinoma
1. Introduction
Heat shock protein (HSP) 10 is a 10 kDa mito-
chondrial chaperone involved in protein folding. It has
been highly conserved during phylogenesis and its
function is strictly related to another mitochondrial
chaperone, the HSP60, in both prokaryotic and
eukaryotic cells [1]. The HSPs are involved in many
cellular responses, including oxidative stress, and
their role has been recently postulated also in cancer
development. However, only a few works have
discussed the possible role of HSP10 during carcino-
genesis [1,2], while the involvement of HSP60 has
been investigated by a number of studies [3–9]. We
have recently showed an up-regulation of HSP60
during carcinogenesis of the large bowel [10] and the
uterine exocervix [11]. We proposed that the over-
expression of HSP60 could have a role during
tumorigenesis, but these data need further support.
In the present study, we described the presence and
the level of expression of HSP10 during colorectal
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and exocervical carcinogenesis, to add new knowl-
edge on the role of these mitochondrial chaperones
during the development of cancer.
2. Materials and methods
2.1. Specimen collection
In order to study the large bowel carcinogenesis,
we collected 15 specimens from normal colonic
mucosa (NC), 15 from tubular adenomas with mild
dysplasia (MA), 15 from tubular adenomas with
severe dysplasia (SA), and 15 from colorectal
adenocarcinomas with an intermediate grade of
differentiation (CA).
In order to study exocervical carcinogenesis, we
collected 20 biopsies from normal exocervices (NE),
20 from low-grade squamous intraepithelial lesions
(L-SIL), 20 from high-grade squamous intraepithelial
lesions (H-SIL), and 20 from squamous carcinomas
with an intermediate grade of differentiation (SC).
A small specimen of fresh tissue from each biopsy
was frozen for Western blotting analysis. The rest of
the biopsy was formalin-fixed and paraffin-embedded
for pathologic diagnosis and immunohistochemical
study.
2.2. Immunohistochemistry
Immunostaining by a streptavidin–biotin complex
method (LSAB2 kit peroxidase, DAKO Corporation,
Carpinteria CA, Cat. No. K0677) was performed
using a primary antibody against HSP10 (Rabbit Anti-
Cpn10 Polyclonal Antibody, StressGen, Biotechnol-
ogies Corp., Victoria, BC, Canada, Cat. No. SPA-110)
at the dilution of 1:400 on 5-micra formalin-fixed
paraffin-embedded sections. After incubation for
10 min with protein block serum-free (DAKO Cor-
poration, Cat. No. X0909), the primary antibody was
added to the sections. Non-immune rabbit serum was
substituted for negative controls. Diaminobenzidine
was used as develop chromogen (DAKO Corporation,
Cat. No. K3467). Hematoxylin aqueous formula
(DAKO Corporation, Cat. No. S2020) was used as
counterstaining. The results were assessed by two
independent observers.
2.3. Quantitative analysis
The expression of HSP10 in the examined speci-
mens was quantified by computer-assisted image
analysis (Colourvision 1.7.6, Improvision, Coventry,
UK). For each biopsy, the tissue was systematically
assessed in two non-serial sections, on the basis of red,
green and blue (RGB) color balance. At the beginning
of each session, the image analysis system was stand-
ardized using the same section of tissue stained for
the HSP10 to ensure reproducibility of analysis. The
digitized image of the standard section was used to
sample interactively an example of the positive stain-
ing and the system was then allowed to select all the
pixels of the same RGB color balance (i.e. positive
staining) within the image. The area of the examined
tissue was then delineated interactively and the per-
centage of positive staining within the tissue was
determined; the color balance and percentual staining
value was recorded for future sessions. At the begin-
ning of each subsequent session, the image analyzer
was calibrated using this section and adjusted to
within ^5% of the original pixel reading. Once the
system had been calibrated using the ‘standard’ slide,
the test sections were analyzed using the same para-
meters. An observer performed measurements of
HSP10 expression. Each tissue section was analyzed
on two separate occasions by two independent
observers; means of the duplicate observations data
were analyzed using Mann–Whitney U test; P , 0:05
was considered significant.
2.4. Western blot analysis
Twenty micrograms of total cell extracts were
applied to each lane along with a protein marker
(Kaleidoscope prestained standard, Bio-Rad, Her-
cules, CA, USA, Cat. No. 1610324). They were
separated by electrophoresis on denaturing 10%
polyacrylamide slab gel (sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE))
and transferred to nitrocellulose membrane (Nitrocell
Paper, Bio-Rad, Cat. No. 1620115). After 1 h at room
temperature (RT) with a blocking buffer (5% low-fat
dried milk in Tampone Buffered Saline (TBS):
50 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.1%
Tween-20) under gentle shaking, the membranes
were incubated with anti-HSP10 primary antibody
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(Rabbit Anti-Cpn10 Polyclonal Antibody, StressGen,
Biotechnologies Corp., Cat. No. SPA-110) at the
dilution of 1:1000, overnight at 48C. After washing,
the membranes were incubated with horseradish
peroxidase (HRP)-conjugated secondary antibody
(anti-rabbit, Pierce, 1:10 000, Cheshire, UK, Cat.
No. 31432) for 1 h at RT with shaking and the specific
binding was detected using a chemiluminescent
substrate (SuperSignal West Pico Chemiluminescent
Substrate, Pierce, Cat. No. 34080) for
autoradiography.
3. Results
NC showed tubular glands of regular aspect with
scattered inflammatory cells in lamina propria
(Fig. 1a). Few cellular elements showed a punctate
staining pattern for HSP10 [quantitative analysis:
percent epithelial staining (range): 6 (2–14)], con-
sistent with a mitochondrial localization, while
connective cells of lamina propria were negative
(Fig. 1a, inset).
MA showed enlarged glands with cell and nuclear
crowding. Inflammatory cells in lamina propria were
abundant (Fig. 1b). Dysplastic glands showed a great
number of positive cells [68 (53–81)], while lamina
propria was negative (Fig. 1b, inset).
SA showed elongated and distorted glands with
interposed abundant inflammatory stroma (Fig. 1c).
Cellular elements in dysplastic glands were strongly
positive [72 (56–90)]. Lamina propria was negative
or, only occasionally, slightly positive in a few cells.
CA showed a cribrous architecture of tumoral
glands; a great number of cells (Fig. 1d) had a diffuse
cytoplasmic staining for HSP10 [77 (60–95)], while
lamina propria showed only scattered positive cells.
The statistical evaluation of quantitative analysis
showed that there was no significant difference
between the levels of expression in MA, SA and
CA, but there was a significant increase in expression
in all three conditions compared with NC, as deter-
mined by both immunohistochemistry and immuno-
blotting. (Figs. 2a and 3a).
NE showed a multi-layered epithelium with scat-
tered positive cells in basal layer (Fig. 1e). Parabasal,
intermediate and superficial layers showed negative
cellular elements (Fig. 1e, inset). The quantitative
analysis showed that the percentage of epithelial
staining was [8 (4–16)]. Lamina propria was negative.
L-SIL showed a mild thickening of epithelium and
an inflammatory stroma (Fig. 1f). We found the
presence of HSP10 in the cells of basal, parabasal and
intermediate layer [433 (27–64)] (Fig. 1f, inset). Few
scattered positive cells were also found in lamina
propria.
H-SIL showed numerous positive cellular elements
in the thickened epithelium (Fig. 1g). These cells were
present in all layers of epithelium (Fig. 1g, inset) [62
(39–75)], while lamina propria showed rare elements
staining for HSP10.
SC were characterized by islets of neoplastic cells
with a positive staining (Fig. 1h). A great number of
tumoral cells stained for HSP10 (Fig. 1h, inset) [84
(73–96)], while the reactive stroma showed scattered
positive elements.
The statistical evaluation of quantitative analysis
showed the presence of significant differences
between the expression of HSP10 in NE, L-SIL,
H-SIL and SC (Fig. 2b). Moreover, Western blot
showed also a growing expression of HSP10 from NE
through SILs to carcinomas (Fig. 3b).
4. Discussion
Heat shock proteins are a highly conserved family
of molecules involved in protein folding in both
prokaryotic and eukaryotic cells [12]. In particular,
HSP10, also known as Cpn10, is the GroES
Escherichia coli homologous protein present in
mammal mitochondria [13]. HSP10 and HSP60
strictly interact in a two-step folding mechanism in
normal prokaryotic and eukaryotic cells [14].
The role of HSPs during carcinogenesis was
postulated and investigated in vivo in many sites, as
lung [15], breast [16], esophageal [17] and ovarian
cancer [18], melanoma [19], lymphoblastic leukemia
and nephroblastoma [20]. In particular, HSP60
involvement in cancer development [7,9–11,21,22],
diagnosis and prognosis [3–6,8] addressed more
studies than did HSP10.
We have recently described the overexpression of
HSP60 in two carcinogenetic models, the ‘adenoma–
carcinoma sequence’ of large bowel [10] and the
‘dysplasia–carcinoma sequence’ of uterine exocervix
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Fig. 1. Immunohistochemical positivity of HSP10 in normal colonic mucosa (a), tubular adenomas with mild dysplasia (b), tubular adenomas
with severe dysplasia (c), colorectal adenocarcinomas with an intermediate grade of differentiation (d), normal exocervices (e), low-grade
squamous intraepithelial lesions (f), high-grade squamous intraepithelial lesions (g) and squamous carcinomas with an intermediate grade of
differentiation (h) at 10 £ magnifications (inset: 40 £ ).
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[11]. HSP60 cytoplasmic accumulation increased
during exocervical carcinogenesis [11], while
HSP60 accumulates early in cytoplasm of tubular
adenomas of large bowel [10]. We proposed that
HSP60 could have an active role in the multi-step
process of carcinogenesis, i.e. during both promotion
and progression steps. In the present study, we evalu-
ated the presence and the level of expression of
HSP10 in normal, dysplastic and neoplastic tissues
obtained from human large bowels and uterine
exocervices.
Immunohistochemical analysis showed positive
staining for HSP10 in normal, dysplastic and neo-
plastic tissues in both large bowel and uterine
exocervix. It was strongest in epithelial cells with
only a few scattered cells in the connective tissue. The
strength of positive staining increased from normal
to carcinoma, as confirmed by quantitative and
molecular analyses. In addition, we found a gradual
accumulation of HSP10 in the ‘dysplasia–carcinoma
sequence’ of uterine exocervix, while it was over-
expressed early in cells of glands of MA. These data
were also confirmed by both quantitative and
molecular analyses.
In the present series of colonic tissues we obtained
similar results to those of Somodevilla-Torres et al.
[23]; they report that normal colonic tissue showed a
punctate staining pattern for HSP10, consistent with a
mitochondrial localization, while malignant bowel
shows an overall increase in staining with diffuse
cytoplasmic staining and localization in secretory
structures and malignant gland spaces.
Rat models of cerebral [24,25] and cardiac
ischemia [26,27] showed a simultaneous over-
expression of HSP10 and HSP60. More recently, an
up-regulation of these chaperones was demonstrated
also in human myocardium during chronic atrial
fibrillation [28]. These data indicate a protective role
of these HSPs during the hypoxic–ischemic stress.
In the present study, the data concerning the
HSP10 expression during colorectal and exocervical
Fig. 2. (a) Statistic evaluation in large bowel carcinogenesis: NC
differed in significant manner by MA, SA and CA; absence of
significant differences among the positivity of MA, SA and CA. (b)
Statistic evaluation in exocervical carcinogenesis: presence of
significant differences among the positivity of NE, L-SIL, H-SIL
and SC.
Fig. 3. Representative Western blot analyses in large bowel (a) and
exocervical (b) carcinogenesis.
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carcinogenesis are similar to those we found for HSP60
[10,11]. This analogous pattern of overexpression
could indicate that activities of HSP10 and HSP60 are
both conserved. As a consequence, this overexpres-
sion could be a protective up-regulation and these
HSPs could have a role in refolding of proteins that
are denatured during carcinogenesis, as BRCA1 in
breast cancer [29] and p16 in many other tumors [30].
Samali et al. [31] recently described a pre-
apoptotic complex among pro-caspase 3, HSP60 and
HSP10 in mitochondria of Jurkat cells. Induction of
apoptosis led to the activation of pro-caspase 3 and its
dissociation from the HSPs, which were released from
mitochondria. This mechanism accelerated caspase-
activation in the cytoplasm of intact cells and
promoted the trigger of apoptotic mechanism. Since
defective apoptosis can induce tumorigenesis [32]
during carcinogenesis, HSP10 and HSP60 could lose
their pro-apoptotic role and these defective proteins
could accumulate in cytoplasm of dysplastic and/or
neoplastic cells. The two proposed mechanisms
(protective up-regulation or defective accumulation)
are not mutually exclusive, but could represent a
continuum in the pathogenesis of tumors, from
dysplasia to cancer.
In conclusion, to our knowledge, this should be the
first study to correlate the simultaneous overexpres-
sion of HSP10 and HSP60 during carcinogenesis. We
believe that these proteins could be functional in the
cytoplasm of both dysplastic and neoplastic cells, but
this hypothesis needs further confirmation. Our data
may stimulate further pathogenetic studies to under-
stand better why these chaperones are overexpressed
during carcinogenesis. Finally, these data could have
also a clinical relevance because HSPs could become
new diagnostic and prognostic tools for the manage-
ment of neoplasms.
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